☰

Anurima Majumder, Ph.D. - Publications

Affiliations: 
2011 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Pharmacology, Physiology Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Majumder A, Hosseinian S, Stroud M, Adhikari E, Saller JJ, Smith MA, Zhang G, Agarwal S, Creixell M, Meyer BS, Kinose F, Bowers K, Fang B, Stewart PA, Welsh EA, et al. Integrated proteomics-based physical and functional mapping of AXL kinase signaling pathways and inhibitors define its role in cell migration. Molecular Cancer Research : McR. PMID 35022314 DOI: 10.1158/1541-7786.MCR-21-0275  0.434
2019 Majumder A, Zhang G, Adhikari E, Fang B, Welsh EA, Koomen JM, Haura EB. Abstract 4543: Proteomic characterization of AXL kinase inhibitors and signaling pathways Cancer Research. 79: 4543-4543. DOI: 10.1158/1538-7445.Am2019-4543  0.524
2019 Majumder A, Boutchueng-Djidjou M, Kim J, Sumi N, Rix U, Haura EB. Abstract C114: Cancer cell induced activation of associated fibroblasts is PDGFR-mediated Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C114  0.474
2018 Wang T, Reingruber J, Woodruff ML, Majumder A, Camarena A, Artemyev NO, Fain GL, Chen J. The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx. The Journal of Biological Chemistry. PMID 30126843 DOI: 10.1074/Jbc.Ra118.004459  0.369
2018 Djidjou MB, Kim J, Han K, Wright G, Majumder A, Fang B, Koomen J, Rix LLR, Rix U, Haura E. Abstract 5089: A quantitative proteomic survey reveals mechanisms of the bi-directional signaling between lung fibroblasts and lung cancer cells Cancer Research. 78: 5089-5089. DOI: 10.1158/1538-7445.Am2018-5089  0.453
2017 Majumder A, Bai Y, Kinose F, Lew ED, Yokoyama Y, Murphy D, Li G, Haura EB. Abstract 335:In situprotein complexes as a measure of AXL signaling and inhibitor response in cell line models of lung cancer Cancer Research. 77: 335-335. DOI: 10.1158/1538-7445.Am2017-335  0.334
2015 Yadav RP, Majumder A, Gakhar L, Artemyev NO. Extended conformation of the proline-rich domain of human aryl hydrocarbon receptor-interacting protein-like 1: implications for retina disease. Journal of Neurochemistry. 135: 165-75. PMID 26139345 DOI: 10.1111/Jnc.13223  0.309
2015 Cheguru P, Majumder A, Artemyev NO. Distinct patterns of compartmentalization and proteolytic stability of PDE6C mutants linked to achromatopsia. Molecular and Cellular Neurosciences. 64: 1-8. PMID 25461672 DOI: 10.1016/J.Mcn.2014.10.007  0.318
2014 Manes G, Cheguru P, Majumder A, Bocquet B, Sénéchal A, Artemyev NO, Hamel CP, Brabet P. A truncated form of rod photoreceptor PDE6 β-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the γ-subunit. Plos One. 9: e95768. PMID 24760071 DOI: 10.1371/Journal.Pone.0095768  0.333
2013 Majumder A, Pahlberg J, Boyd KK, Kerov V, Kolandaivelu S, Ramamurthy V, Sampath AP, Artemyev NO. Transducin translocation contributes to rod survival and enhances synaptic transmission from rods to rod bipolar cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 12468-73. PMID 23836670 DOI: 10.1073/Pnas.1222666110  0.349
2012 Majumder A, Magis AT, Park SO, Figueroa NC, Baskin R, Kirabo A, Allan RW, Zhao ZJ, Bisht KS, Keseru GM, Sayeski PP. A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth. Experimental Hematology. 40: 22-34. PMID 22019628 DOI: 10.1016/J.Exphem.2011.10.003  0.72
2011 Kirabo A, Park SO, Majumder A, Gali M, Reinhard MK, Wamsley HL, Zhao ZJ, Cogle CR, Bisht KS, Keserü GM, Sayeski PP. The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia (New York, N.Y.). 13: 1058-68. PMID 22131881 DOI: 10.1593/Neo.111112  0.733
2011 Majumder A, Kirabo A, Karrupiah K, Tsuda S, Caldwell-Busby J, Cardounel AJ, Keseru GM, Sayeski PP. Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments. Biochemistry. 50: 7774-86. PMID 21823612 DOI: 10.1021/Bi200847N  0.76
2011 Kirabo A, Embury J, Kiss R, Polgár T, Gali M, Majumder A, Bisht KS, Cogle CR, Keseru GM, Sayeski PP. The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo. The Journal of Biological Chemistry. 286: 4280-91. PMID 21127060 DOI: 10.1074/Jbc.M110.200774  0.76
2011 Majumder A, Kirabo A, Karrupiah K, Tsuda S, Caldwell-Busby J, Cardounel AJ, Sayeski PP. Abstract 5127: G6-mediated inhibition of Jak2 tyrosine kinase correlates with the cleavage and cellular reorganization of vimentin Cancer Research. 71: 5127-5127. DOI: 10.1158/1538-7445.Am2011-5127  0.761
2010 Baskin R, Majumder A, Sayeski PP. The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Current Medicinal Chemistry. 17: 4551-8. PMID 21062251 DOI: 10.2174/092986710794182953  0.657
2010 Majumder A, Govindasamy L, Magis A, Kiss R, Polgár T, Baskin R, Allan RW, Agbandje-McKenna M, Reuther GW, Keseru GM, Bisht KS, Sayeski PP. Structure-function correlation of G6, a novel small molecule inhibitor of Jak2: indispensability of the stilbenoid core. The Journal of Biological Chemistry. 285: 31399-407. PMID 20667821 DOI: 10.1074/Jbc.M110.168211  0.76
2010 Majumder A, Sayeski PP. Tyrosine-protein kinase JAK2 inhibitors for the treatment of myeloproliferative neoplasms Drugs of the Future. 35: 651-660. DOI: 10.1358/Dof.2010.035.08.1514131  0.658
Show low-probability matches.